Origin of the TTC values for compounds that are genotoxic and/or carcinogenic and an approach for their re-evaluation

Abstract The threshold of toxicological concern (TTC) approach is a resource-effective de minimis method for the safety assessment of chemicals, based on distributional analysis of the results of a large number of toxicological studies. It is being increasingly used to screen and prioritize substances with low exposure for which there is little or no toxicological information. The first step in the approach is the identification of substances that may be DNA-reactive mutagens, to which the lowest TTC value is applied. This TTC value was based on the analysis of the cancer potency database and involved a number of assumptions that no longer reflect the state-of-the-science and some of which were not as transparent as they could have been. Hence, review and updating of the database is proposed, using inclusion and exclusion criteria reflecting current knowledge. A strategy for the selection of appropriate substances for TTC determination, based on consideration of weight of evidence for genotoxicity and carcinogenicity is outlined. Identification of substances that are carcinogenic by a DNA-reactive mutagenic mode of action and those that clearly act by a non-genotoxic mode of action will enable the protectiveness to be determined of both the TTC for DNA-reactive mutagenicity and that applied by default to substances that may be carcinogenic but are unlikely to be DNA-reactive mutagens (i.e. for Cramer class I–III compounds). Critical to the application of the TTC approach to substances that are likely to be DNA-reactive mutagens is the reliability of the software tools used to identify such compounds. Current methods for this task are reviewed and recommendations made for their application.

[1]  J. Huff,et al.  The carcinogenesis bioassay in perspective: application in identifying human cancer hazards. , 1995, Environmental health perspectives.

[2]  Wout Slob,et al.  Benchmark dose and the three Rs. Part I. Getting more information from the same number of animals , 2014, Critical reviews in toxicology.

[3]  David Y. Lai,et al.  PPARα Agonist-Induced Rodent Tumors: Modes of Action and Human Relevance , 2003 .

[4]  N. Skovgaard.  Safety evaluation of certain food additives , 2001 .

[5]  J. Bucher,et al.  Evaluating the human relevance of chemically induced animal tumors. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.

[6]  Martin Paparella,et al.  International regulatory needs for development of an IATA for non-genotoxic carcinogenic chemical substances. , 2016, ALTEX.

[7]  R. Tennant,et al.  Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the U.S. NTP. , 1991, Mutation research.

[8]  Lutz Müller,et al.  In vivo studies in the mouse to define a threshold for the genotoxicity of EMS and ENU. , 2009, Mutation research.

[9]  Lutz Müller,et al.  Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens II. Further analysis of mammalian cell results, relative predictivity and tumour profiles. , 2006, Mutation research.

[10]  A. Bailey,et al.  A tiered approach to threshold of regulation. , 1999, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[11]  Alexander Tropsha,et al.  Recent Advances in Development, Validation, and Exploitation of QSAR Models , 2010, Burger's Medicinal Chemistry and Drug Discovery.

[12]  A. Rulis.  De Minimis and the Threshold of Regulation , 2018 .

[13]  U. Epa.  Guidelines for carcinogen risk assessment , 1986 .

[14]  M E Meek,et al.  New developments in the evolution and application of the WHO/IPCS framework on mode of action/species concordance analysis , 2013, Journal of applied toxicology : JAT.

[15]  Joint Fao,et al.  Toxicological evaluation of certain food additives and contaminants , 1987 .

[16]  R. Kroes.  Structure-Based Thresholds of Toxicological Concern (TTC): Guidance for Application to Substances Present at Low Levels in the Diet , 2004, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[17]  R. Harvey.  Polycyclic hydrocarbons and carcinogenesis , 1985 .

[18]  M T D Cronin,et al.  A review of the electrophilic reaction chemistry involved in covalent DNA binding , 2010, Critical reviews in toxicology.

[19]  P. Lohman.  International Commission for Protection against Environmental Mutagens and Carcinogens. , 1980, Cancer research.

[20]  M. Shou,et al.  Species Differences of Drug‐Metabolizing Enzymes , 2011 .

[21]  T. Pfister,et al.  Literature review on the genotoxicity, reproductive toxicity, and carcinogenicity of ethyl methanesulfonate. , 2009, Toxicology letters.

[22]  L. Hall,et al.  Three new consensus QSAR models for the prediction of Ames genotoxicity. , 2004, Mutagenesis.

[23]  Jennifer Seed,et al.  A Framework for Human Relevance Analysis of Information on Carcinogenic Modes of Action , 2003, Critical reviews in toxicology.

[24]  R. Tennant,et al.  Chemical structure, Salmonella mutagenicity and extent of carcinogenicity as indicators of genotoxic carcinogenesis among 222 chemicals tested in rodents by the U.S. NCI/NTP. , 1988, Mutation research.

[25]  R Serafimova,et al.  Identification of the structural requirements for mutagencitiy, by incorporating molecular flexibility and metabolic activation of chemicals. II. General Ames mutagenicity model. , 2007, Chemical research in toxicology.

[26]  R A Ford,et al.  Correlation of structural class with no-observed-effect levels: a proposal for establishing a threshold of concern. , 1996, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[27]  Nigel Greene,et al.  It's difficult, but important, to make negative predictions. , 2016, Regulatory toxicology and pharmacology : RTP.

[28]  J Ashby,et al.  International Commission for Protection Against Environmental Mutagens and Carcinogens. Two million rodent carcinogens? The role of SAR and QSAR in their detection. , 1994, Mutation research.

[29]  L. Müller,et al.  MNT and MutaMouse studies to define the in vivo dose response relations of the genotoxicity of EMS and ENU. , 2009, Toxicology letters.

[30]  Mirjam Luijten,et al.  An integrative test strategy for cancer hazard identification , 2016, Critical reviews in toxicology.

[31]  Valérie Zuang,et al.  Alternative (non-animal) methods for cosmetics testing: current status and future prospects—2010 , 2011, Archives of Toxicology.

[32]  B. Ames,et al.  Sixth plot of the carcinogenic potency database: results of animal bioassays published in the General Literature 1989 to 1990 and by the National Toxicology Program 1990 to 1993. , 1995, Environmental health perspectives.

[33]  Samuel J. Webb,et al.  Self organising hypothesis networks: a new approach for representing and structuring SAR knowledge , 2014, Journal of Cheminformatics.

[34]  Joint Fao,et al.  Safety evaluation of certain food additives , 1999 .

[35]  Wen Xie,et al.  Mode of action and human relevance analysis for nuclear receptor-mediated liver toxicity: A case study with phenobarbital as a model constitutive androstane receptor (CAR) activator , 2014, Critical reviews in toxicology.

[36]  Gary M Williams,et al.  DNA-Reactive Carcinogens: Mode of Action and Human Cancer Hazard , 2005, Critical reviews in toxicology.

[37]  Ovanes Mekenyan,et al.  Identification of the structural requirements for mutagenicity by incorporating molecular flexibility and metabolic activation of chemicals I: TA100 model. , 2004, Chemical research in toxicology.

[38]  M T D Cronin,et al.  Development of new structural alerts suitable for chemical category formation for assigning covalent and non-covalent mechanisms relevant to DNA binding. , 2012, Mutation research.

[39]  José Cortiñas Abrahantes,et al.  Update: use of the benchmark dose approach in risk assessment , 2017, EFSA journal. European Food Safety Authority.

[40]  R A Ford,et al.  Estimation of toxic hazard--a decision tree approach. , 1978, Food and cosmetics toxicology.

[41]  J. Corton,et al.  Mode of action framework analysis for receptor-mediated toxicity: The peroxisome proliferator-activated receptor alpha (PPARα) as a case study , 2014, Critical reviews in toxicology.

[42]  Raffaella Corvi,et al.  an in vitro mammalian cell genotoxicity test results be used to omplement positive results in the Ames test and help predict arcinogenic or in vivo genotoxic activity ? II . Construction and nalysis of a consolidated database , 2014 .

[43]  David H Phillips,et al.  Mutagenicity testing for chemical risk assessment: update of the WHO/IPCS Harmonized Scheme. , 2009, Mutagenesis.

[44]  H. van Steeg,et al.  Mechanisms of non-genotoxic carcinogens and importance of a weight of evidence approach. , 2009, Mutation research.

[45]  Alan R. Boobis,et al.  IPCS Framework for Analyzing the Relevance of a Noncancer Mode of Action for Humans , 2008, Critical reviews in toxicology.

[46]  J H Weisburger,et al.  Carcinogen testing: current problems and new approaches. , 1981, Science.

[47]  J P Frawley,et al.  Scientific evidence and common sense as a basis for food-packaging regulations. , 1967, Food and cosmetics toxicology.

[48]  S. Dertinger,et al.  In vivo assessment of Pig‐a gene mutation—recent developments and assay validation , 2011, Environmental and molecular mutagenesis.

[49]  E Kennepohl,et al.  A procedure for the safety evaluation of flavouring substances. Joint FAO/WHO Expert Committee on Food Additives. , 1999, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[50]  Raffaella Corvi,et al.  How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: Report of an ECVAM Workshop. , 2007, Mutation research.

[51]  G. Jenkins,et al.  Mechanistic influences for mutation induction curves after exposure to DNA-reactive carcinogens. , 2007, Cancer research.

[52]  T. Singer,et al.  EMS in Viracept--the course of events in 2007 and 2008 from the non-clinical safety point of view. , 2009, Toxicology letters.

[53]  Angelo Moretto,et al.  Risk assessment in the 21st century: Roadmap and matrix , 2014, Critical reviews in toxicology.

[54]  Philip Carthew,et al.  Selection of appropriate tumour data sets for Benchmark Dose Modelling (BMD) and derivation of a Margin of Exposure (MoE) for substances that are genotoxic and carcinogenic: considerations of biological relevance of tumour type, data quality and uncertainty assessment. , 2014, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[55]  Emilio Benfenati,et al.  Evaluation of QSAR Models for the Prediction of Ames Genotoxicity: A Retrospective Exercise on the Chemical Substances Registered Under the EU REACH Regulation , 2014, Journal of environmental science and health. Part C, Environmental carcinogenesis & ecotoxicology reviews.

[56]  Johann Gasteiger,et al.  New Publicly Available Chemical Query Language, CSRML, To Support Chemotype Representations for Application to Data Mining and Modeling , 2015, J. Chem. Inf. Model..

[57]  Dieter Lang,et al.  Predicting drug metabolism: experiment and/or computation? , 2015, Nature Reviews Drug Discovery.

[58]  Andrew Teasdale,et al.  ICH M7: Assessment and Control of DNA Reactive (Mutagenic) Impurities in Pharmaceuticals to Limit Potential Carcinogenic Risk , 2017 .

[59]  L. Bernstein,et al.  Summary of carcinogenic potency and positivity for 492 rodent carcinogens in the carcinogenic potency database. , 1989, Environmental health perspectives.

[60]  U. Tillmann,et al.  A systematic approach for evaluating the quality of experimental toxicological and ecotoxicological data. , 1997, Regulatory toxicology and pharmacology : RTP.

[61]  Ovanes Mekenyan,et al.  Identifying the structural requirements for chromosomal aberration by incorporating molecular flexibility and metabolic activation of chemicals. , 2007, Chemical research in toxicology.

[62]  Judith C. Madden,et al.  Assessment of Methods To Define the Applicability Domain of Structural Alert Models , 2011, J. Chem. Inf. Model..

[63]  D. Jerina,et al.  The Bay Region Theory of Polycyclic Aromatic Hydrocarbon Carcinogenesis , 1985 .

[64]  Ian C. Munro Rapporteur.  Safety assessment procedures for indirect food additives: An overview: Report of a workshop , 1990 .

[65]  B. Ames,et al.  The fifth plot of the Carcinogenic Potency Database: results of animal bioassays published in the general literature through 1988 and by the National Toxicology Program through 1989. , 1993, Environmental health perspectives.

[66]  Carolyn Vickers,et al.  IPCS framework for analysing the relevance of a cancer mode of action for humans , 2006 .

[67]  Deborah M Proctor,et al.  Mode-of-action framework for evaluating the relevance of rodent forestomach tumors in cancer risk assessment. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[68]  M. Pike,et al.  A carcinogenic potency database of the standardized results of animal bioassays , 1984, Environmental health perspectives.

[69]  David Kirkland,et al.  Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens III. Appropriate follow-up testing in vivo. , 2005, Mutation research.